Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Home > Science Hub > Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials
Back to the list

April 7, 2025

Matt Clutter

You might also be interested by

Posters

Advancing B-Cell Monitoring in B-Cell-Depleting Therapies for Autoimmune Disorders

June 8, 2026

More info

Uncategorized

Accelerating spectral flow cytometry assay development for clinical trials with a flexible panel design

June 8, 2026

More info

News

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

May 29, 2026

More info

News

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

May 27, 2026

More info